KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 76,836 Value ($000) $182 Avg Close — Range —
Q3 2023
Shares 52,168 Value ($000) $73 Avg Close — Range —